PIPr Therapeutics
Developer of precision therapeutics designed to target and block the root causes of diverse, serious diseases triggered by intestinal inflammation. The company's therapeutics identify and characterize...
Valuation
$10M
Market implied
Share Price
N/A
Total Raised
$36.4M
Last Round
N/A